GSK has announced positive headline outcomes from a Phase III trial of Blenrep with bortezomib and dexamethasone for multiple ...

The awards are presented annually to organizations in the Greater Philadelphia and Triangle (North Carolina) regions.

Global stocks fell after Jerome Powell signaled the Federal Reserve was in no rush to cut interest rates, and unease built ...

GSK’s 3 billion pounds sterling peak sales goal for its multiple myeloma drug Blenrep appears increasingly attainable thanks ...

GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects multi-blockbuster ...

Nina Mojas, senior vice president, oncology global product strategy, GSK, said: “At GSK, we continue to develop new therapies for patients with gynaecologic cancers, yet we know there are also ...

Jitters over the health of the UK economy have been fuelled by today’s weaker-than-expected GDP release. September’s 0.1% ...

LONDON, UK I 14, 2024 I GSK plc (LSE/NYSE: GSK) today announced positive headline results from a planned interim analysis of the DREAMM-7 ...

Shares in European vaccine-makers fell in early trade on Friday after US President-elect Donald Trump said he had selected Robert F. Kennedy Jr., who has previously spread misinformation on vaccines, ...

Veeva Systems (NYSE: VEEV) today announced that Boehringer Ingelheim is the latest global top 20 biopharma company to commit ...

For the past three years, biotechs and pharmas have renamed, rebranded and more in a bid to refresh their corporate appeal. ...

Royalty Pharma inaugural Prize for Impact in Healthcare awarded to Michael Milken, the founder of the Milken Institute, Faster Cures & the ...